The • Vasospasm of the basilar artery of the cat was induced by subarachnoid bleeding and was observed by a transoral approach to the vessel. Intravenous Isordil (2 to 4 mg/kg) given following vasospasm produced vasodilatation with minimal arterial hypotension. Cyclospasmol, administered intravenously after vasospasm or orally prior to vasospasm, was ineffective in relieving or preventing basilar artery spasm.
Introduction
• Probably the most significant consequence of cerebrovascular spasm is the secondary ischemia to the brain. Because of the severe intracranial vascular spasm that has been seen to accompany subarachnoid hemorrhage, 1 studies have been carried out in our laboratories to document, by direct observations, vascular spasm in the basilar artery of the cat induced by autogenous subarachnoid bleeding. 2 ' a Blood-induced vasospasm was found to be relatively stable and persistent for some time when observed 15 minutes after bleeding had occurred. Studies have begun to identify more precisely the blood component responsible for this spasm. 4 Meanwhile, several potential spasmolytic agents are being investigated. 5 Choline chloride has been shown to possess vasodilatory properties when given intravenously (I.V.) to cats with bloodinduced spasm of the basilar artery.
0 Isordil (isosorbide dinitrate) and Cyclospasmol (3, 5, 5- 
Methods
Adult mongrel cats were anesthetized with intraperitoneal sodium pentobarbital. Through a femoral cut-down, arterial and venous catheters were inserted for measurement of arterial blood pressure and I.V. drug injections. The basilar artery was then exposed by the transoral approach previously described. 2 Spasm was induced by tearing a small vessel on the surface of the pons and allowing temporary subarachnoid hemorrhage. This technique has been shown to produce vasospasm which is persistent for at least 100 minutes." A dissecting microscope and camera were used to observe and photograph the spasm and its response to I.V. drug injection. The photographed vessels were later projected onto a screen for standard magnification and diameter measurement. Blood vessel changes were expressed as -(constriction) or + (dilatation).
Bleeding-induced spasm was allowed to stabilize for 15 minutes prior to drug injection. Isordil was evaluated over a dose range of 0.19 to 6.0 mg/kg (eight cats). The dosage of Cyclospasmol varied from 5 to 30 mg/kg (seven cats). Cyclospasmol requires a nonaqueous medium to prepare an injection solution which is of fair physical stability. Thus, a stock solution was made fresh for each experiment consisting of 40 mg Cyclospasmol dissolved in 2 gm Tween 80, 1 gm ethanol, and 7 ml of 0.85% NaCl. (This combination of solvents was found to produce no change in basilar artery diameter when injected I.V.) In a smaller group of three cats, each animal was pretreated with oral Cyclospasmol, 100 mg twice daily for 7 to 61 days, and the subsequent ability of the basilar artery to constrict following bleeding and/or topical application of a spasmogenic platelet fraction preparation was observed. The platelet fraction preparation was the same as that described earlier. Pretreatment with Cyclospasmol chronically over 7 to 61 days did not prevent the development of bleeding spasm (table 2) or spasm induced with a platelet fraction ( fig. 3) . 
Discussion
Although chemical vasodilatation has been used in the past in the treatment of cerebral vasospastic and arteriosclerotic phenomena, it has been done on an empirical basis and results of therapy have been based upon indirect assay techniques. Isordil has not been advocated for cerebrovascular disease. On the other hand, several clinical studies have used Cyclospasmol. Van der Drift reported treatment of 200 patients with ischemic cerebrovascular disease and felt that this drug was helpful clinically in reducing ischemic attacks, although he emphasized the difficulties in obtaining objective data and the need for a control series. 10 Eichhorn, in a series of randomized patients, used isotope flow curves recorded over the torcular to determine any effect of Cyclospasmol upon the flow curve pattern and concluded that drug treatment increased cerebral blood volume and 328 reduced pathologically lengthened circulation time in mild to moderate cases of cerebral vascular insufficiency. 8 Similar conclusions were reached by Kuhn using serial cerebral angiography circulation times, although there were no control patients in this series and the precise comparison of data on a chronic basis is difficult.
0
In our experiments Cyclospasmol, administered acutely after vasospasm or chronically prior to vasospasm, was ineffective in relieving or preventing basilar artery spasm induced with bleeding or a platelet fraction. Despite these negative findings, it is still possible that Cyclospasmol possesses vasodilatory properties at the arteriolar level. Isordil administered following basilar artery spasm produced vasodilatation with minimal arterial hypotension. It would seem unlikely that the vasodilatation was secondary to hypotension since a similar 2 ' 5 Since the vasospasm seen clinically by angiography following subarachnoid hemorrhage so characteristically involves the major arteries at the base of the brain, Isordil may deserve clinical trial in this situation whereas Cyclospasmol may yet prove useful with cerebral ischemic problems of a more peripheral nature.
